Taken together with analysis of Zeb1–/– HSCs, these data suggest that Zeb1-mediated control of HSC self-renewal, apoptosis, and differentiation fates is integral to suppressing the vulnerability of HSCs to leukemic transformation and disease progression in AML. This evidence concerns the gene ZEB1 and acute myeloid leukemia.